Nalaganje...

New possibilities of pharmacotherapy for systemic lupus erythematosus: Prospects for the use of anifrolumab (monoclonal antibodies to type I interferon receptor)

Systemic lupus erythematosus (SLE) is a systemic autoimmune rheumatic disease of unknown etiology, characterized by overproduction of organ-specific autoantibodies to various components of the cell nucleus and the development of immune-inflammatory damage to internal organs. According to modern conc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: E. L. Nasonov, A. S. Avdeeva, T. V. Popkova
Format: Artigo
Jezik:Russo
Izdano: IMA-PRESS LLC 2021-10-01
Serija:Научно-практическая ревматология
Teme:
Online dostop:https://rsp.mediar-press.net/rsp/article/view/3072
Oznake: Označite
Brez oznak, prvi označite!